These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 8600516
1. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Science; 1996 Apr 05; 272(5258):104-7. PubMed ID: 8600516 [Abstract] [Full Text] [Related]
4. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. Corthésy B, Benureau Y, Perrier C, Fourgeux C, Parez N, Greenberg H, Schwartz-Cornil I. J Virol; 2006 Nov 05; 80(21):10692-9. PubMed ID: 16956954 [Abstract] [Full Text] [Related]
5. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo. Lappalainen S, Pastor AR, Tamminen K, López-Guerrero V, Esquivel-Guadarrama F, Palomares LA, Vesikari T, Blazevic V. Hum Vaccin Immunother; 2014 Nov 05; 10(7):2039-47. PubMed ID: 25424814 [Abstract] [Full Text] [Related]
6. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Choi AH, Knowlton DR, McNeal MM, Ward RL. Virology; 1997 May 26; 232(1):129-38. PubMed ID: 9185596 [Abstract] [Full Text] [Related]
7. Protective immunity induced by rotavirus DNA vaccines. Chen SC, Fynan EF, Robinson HL, Lu S, Greenberg HB, Santoro JC, Herrmann JE. Vaccine; 1997 Jun 26; 15(8):899-902. PubMed ID: 9234543 [Abstract] [Full Text] [Related]
8. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. Schwartz-Cornil I, Benureau Y, Greenberg H, Hendrickson BA, Cohen J. J Virol; 2002 Aug 26; 76(16):8110-7. PubMed ID: 12134016 [Abstract] [Full Text] [Related]
9. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant. Siadat-Pajouh M, Cai L. Viral Immunol; 2001 Aug 26; 14(1):31-47. PubMed ID: 11270595 [Abstract] [Full Text] [Related]
10. Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA. Johansen K, Svensson L. Arch Virol; 1997 Aug 26; 142(7):1491-8. PubMed ID: 9267458 [Abstract] [Full Text] [Related]
11. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies. García-Díaz A, López-Andújar P, Rodríguez Díaz J, Montava R, Torres Barceló C, Ribes JM, Buesa J. Vaccine; 2004 Dec 09; 23(4):489-98. PubMed ID: 15530697 [Abstract] [Full Text] [Related]
16. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. McNeal MM, Stone SC, Basu M, Bean JA, Clements JD, Hendrickson BA, Choi AH, Ward RL. Virology; 2006 Mar 15; 346(2):338-47. PubMed ID: 16375942 [Abstract] [Full Text] [Related]
17. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Choi AH, Basu M, Rae MN, McNeal MM, Ward RL. Virology; 1998 Oct 10; 250(1):230-40. PubMed ID: 9770437 [Abstract] [Full Text] [Related]
20. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus. Giammarioli AM, Mackow ER, Fiore L, Greenberg HB, Ruggeri FM. Virology; 1996 Nov 01; 225(1):97-110. PubMed ID: 8918537 [Abstract] [Full Text] [Related] Page: [Next] [New Search]